Applied Therapeutics Inc (NASDAQ:APLT) stock Posted Gross Margin of 95.68 percent in Last Year: Is Justifiable?
RBC Capital Mkts raised the price target for the Applied Therapeutics Inc (NASDAQ:APLT) stock to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The research report from Barclays has downgraded the stock from Overweight to Equal Weight, with a price target set at $7. The stock was downgraded by Goldman, […]
Stay away from Applied Therapeutics Inc (APLT) Stock or get into it
RBC Capital Mkts raised the price target for the Applied Therapeutics Inc (NASDAQ:APLT) stock to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The research report from Barclays has downgraded the stock from Overweight to Equal Weight, with a price target set at $7. The stock was downgraded by Goldman, […]
What are the chances of the Applied Therapeutics Inc (APLT) Stock tortoise growing into a hare?
RBC Capital Mkts raised the price target for the Applied Therapeutics Inc (NASDAQ:APLT) stock to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The research report from Barclays has downgraded the stock from Overweight to Equal Weight, with a price target set at $7. The stock was downgraded by Goldman, […]
It’s not the right time to quit: Applied Therapeutics Inc (APLT) Stock
RBC Capital Mkts raised the price target for the Applied Therapeutics Inc (NASDAQ:APLT) stock to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The research report from Barclays has downgraded the stock from Overweight to Equal Weight, with a price target set at $7. The stock was downgraded by Goldman, […]
The high-quality value of Applied Therapeutics Inc (APLT) Stock is hidden beneath the surface
RBC Capital Mkts raised the price target for the Applied Therapeutics Inc (NASDAQ:APLT) stock to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The research report from Barclays has downgraded the stock from Overweight to Equal Weight, with a price target set at $7. The stock was downgraded by Goldman, […]
Analysts Estimated Revenue of $3.33M in the current quarter for Applied Therapeutics Inc (NASDAQ:APLT) Stock
RBC Capital Mkts raised the price target for the Applied Therapeutics Inc (NASDAQ:APLT) stock to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The research report from Barclays has downgraded the stock from Overweight to Equal Weight, with a price target set at $7. The stock was downgraded by Goldman, […]
